How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ..
Randomised placebo-controlled trials (RPCTs) are the gold standard for evaluating novel treatments. However, this design is rarely used in the context of orthopaedic interventions where participants are assigned to a real or placebo surgery. The present study examines attitudes towards RPCTs for orthopaedic surgery among 687 orthopaedic surgeons across the USA. When presented with a vignette describing an RPCT for orthopaedic surgery, 52.3% of participants viewed it as 'completely' or 'mostly' unethical. Participants were also asked to rank-order the value of five different types of evidence supporting the efficacy of a surgery, ranging from RPCT to an anecdotal report. Responses regarding RPCTs were polarised with 26.4% viewing it as the least valuable (even less valuable than an anecdote) and 35.7 .% viewing it as the most valuable. Where equipoise exists, if we want to subject orthopaedic surgeries to the highest standard of evidence (RPCTs) before they are implemented in clinical practice, it will be necessary to educate physicians on the value and ethics of placebo surgery control conditions. Otherwise, invasive procedures may be performed without any benefits beyond possible placebo effects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2022 |
|---|---|
| Enthalten in: |
Journal of medical ethics - (2022) vom: 29. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bernstein, Michael H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 30.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1136/jme-2022-108221 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346906652 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346906652 | ||
| 003 | DE-627 | ||
| 005 | 20240331000541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jme-2022-108221 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1357.xml |
| 035 | |a (DE-627)NLM346906652 | ||
| 035 | |a (NLM)36175126 | ||
| 035 | |a (PII)medethics-2022-108221 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bernstein, Michael H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a Randomised placebo-controlled trials (RPCTs) are the gold standard for evaluating novel treatments. However, this design is rarely used in the context of orthopaedic interventions where participants are assigned to a real or placebo surgery. The present study examines attitudes towards RPCTs for orthopaedic surgery among 687 orthopaedic surgeons across the USA. When presented with a vignette describing an RPCT for orthopaedic surgery, 52.3% of participants viewed it as 'completely' or 'mostly' unethical. Participants were also asked to rank-order the value of five different types of evidence supporting the efficacy of a surgery, ranging from RPCT to an anecdotal report. Responses regarding RPCTs were polarised with 26.4% viewing it as the least valuable (even less valuable than an anecdote) and 35.7 .% viewing it as the most valuable. Where equipoise exists, if we want to subject orthopaedic surgeries to the highest standard of evidence (RPCTs) before they are implemented in clinical practice, it will be necessary to educate physicians on the value and ethics of placebo surgery control conditions. Otherwise, invasive procedures may be performed without any benefits beyond possible placebo effects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a pain management | |
| 700 | 1 | |a Rosenfield, Maayan N |e verfasserin |4 aut | |
| 700 | 1 | |a Blease, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Magill, Molly |e verfasserin |4 aut | |
| 700 | 1 | |a Terek, Richard M |e verfasserin |4 aut | |
| 700 | 1 | |a Savulescu, Julian |e verfasserin |4 aut | |
| 700 | 1 | |a Beaudoin, Francesca L |e verfasserin |4 aut | |
| 700 | 1 | |a Rich, Josiah D |e verfasserin |4 aut | |
| 700 | 1 | |a Wartolowska, Karolina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical ethics |d 1976 |g (2022) vom: 29. Sept. |w (DE-627)NLM000033065 |x 1473-4257 |7 nnns |
| 773 | 1 | 8 | |g year:2022 |g day:29 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/jme-2022-108221 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 29 |c 09 | ||